Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

...

Author

  • The Perth Group

  • Valendar Turner

Publisher

  • -

Category

  • HIV Tests

Topic

  • HIV Test Accuracy

  • ELISA

  • Western Blot

  • HIV Antibody

  • Viral Load Reliability

Article Type

  • Editorial article

Publish Year

  • -

Meta Description

  • The content discusses the reliability of HIV antibody tests, highlighting a study by Colonel Donald Burke, and the varying standards for a positive result globally.

Summary

  • This is a radio broadcast discussing the specificity of HIV antibody tests. The problem is determining if a positive test result indicates HIV infection or another cause. The specificity of the test is crucial in providing accurate results. To determine specificity, data on negative tests and individuals without HIV infection is needed. The experiment should include individuals with a wide range of antibodies to different agents. The HIV Western blot test is used, but the criteria for a positive result vary globally. The study by Colonel Donald Burke is considered the definitive proof of the test's specificity. The failure to validate the antibody tests against virus isolation is a significant omission. Therefore, these tests should not be used to diagnose HIV infection without further verification.

Meta Tag

  • HIV

  • Antibody Tests

  • Infection

  • Western Blot

  • ELISA

  • Donald Burke

  • Seroprevalence

  • False Positives

  • Specificity

  • Cross-reacting Antibodies

  • Blood Donors

  • Positive Result

Featured Image

Featured Image Alt Tag

  • Keyword of the image

By Valendar Turner
Department of Emergency Medicine, Royal Perth
Hospital, Perth, Western Australia

...

Author Tag

...

Publisher Tag

...

Topic Tag

...

  • #Valendar Turner

#HIV Tests

...

#ELISA

...

...

#Viral Load

...

What evidence authenticates a positive HIV antibody test as proof of HIV infection? This question has greatly interested me because those of us who work in Emergency Medicine spend a considerable part of our lives exposed to other people's blood and body fluids, a circumstance which, according to the experts, places us under constant threat of death from AIDS. Ironically, if the experts are right, the life we save may cost us our own and it's little wonder that some of us have pursued the question of proving HIV infection to the very limits. From the early days of AIDS I was fortunate to collaborate with Eleni Eleopulos, a Biophysicist at the Royal Perth Hospital, John Papadimitriou, Professor of Pathology at the University of Western Australia, and other colleagues, and in one of our papers, published in June 1993 in the journal Bio/Technology [1], we were compelled to confront many unsettling conclusions about the HIV antibody tests, none of which accord with current wisdom. Some of these I would like to share with you today.

...

In the entire AIDS literature there is only one study, that of Colonel Donald Burke and his colleagues [3] from the Walter Reed Army Institute, which is widely regarded as the definitive proof of the specificity of the HIV Western blot. Over an eighteen month period Burke and his colleagues tested 1.2 million applicants for US military service. Burke's testing procedure was a progression through two ELISAs and two Western blots. From these data the HIV seroprevalence was found to be 1.48/1000. Burke then retrospectively investigated a highly selected sample of this population in which the seroprevalence was one tenth that of the 1.2 million. This group comprised 135,187 persons aged 17-18 years who resided in rural areas where the cumulative incidence of AIDS was low. Many would assume this group to be no different from healthy blood donors and regard all HIV positives as false positives but Burke and his colleagues' premises were the opposite. Assuming there were true positives amongst healthy, rural American youth and wishing to evaluate the false positive rate and specificity of the Western blot Burke needed to define HIV infection. This was done by performing a panel of four more antibody tests on sera from the 15 out of 135,187 applicants who had already been found twice ELISA and twice Western blot positive. Two of the extra tests were other Western blots and two were similar tests. Any individual positive in all four extra tests, thereby making a total of eight positive antibody tests, was deemed HIV infected. Those who failed any of the extra four tests were deemed non-HIV infected. Of the 15, one failed to complete the panel and thus Burke conceded only one, not fifteen, false-positives. From these data Burke calculated the specificity of the HIV Western blot to be in excess of 99.9%. There are many flaws in this study and they are outlined in reference 1. Here I wish to draw to your attention to the fact that an antibody test, even if repeated and found positive a thousand times, does not prove the presence of a viral infection.

References

Expand
titleClick here to expand..
  1. Eleopulos-Papadopulos E, Turner VF, Papadimitriou JM. 1993. Is a positive Western blot proof of HIV infection? Bio/Technology 11:696-707.

  2. Eleopulos-Papadopulos E, Turner VF, Papadimitriou JM. 1993. Has Gallo proven the role of HIV in AIDS? Emergency Medicine [Australia] 5:113-123.

  3. Burke DS, Brundage, JF, Redfield, RR et al. 1988. Measurement of the false positive rate in a screening program for human immunodeficiency virus infections. NEJM 319: 961-964.

  4. Strandstrom HV, Higgins JR, Mossie K, et al. Studies with canine sera that contain antibodies which recognize human immunodeficiency virus structural proteins. Cancer Res 1990; 50: 5628s-5630s.

  5. Mortimer P, Codd A, Connolly J, et al. Towards error free HIV diagnosis: notes on laboratory practice. PHLS Microbiol Digest 1992; 9: 61-64.

  6. O'Hara CJ, Groopmen JE, Federman M. 1988. The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related lymphadenopathy syndromes. Human Pathology 19:545-549.

  7. Defer C, Agut H, Garbarg-Chenon A. 1992. Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS 6:659-663.